A Prospective, Observational, Cohort Study to Assess the Efficacy and Safety of Prolonged-Release Fampridine in Cognition, Fatigue, Depression, and Quality of Life in Multiple Sclerosis Patients: The FAMILY Study
mediaposted on 23.12.2020, 16:25 by Dimos D. Mitsikostas, Triantafyllos Doskas, Stylianos Gkatzonis, Nikolaos Fakas, Maria Maltezou, Dimitrios Papadopoulos, Rania Gourgioti, Panayiotis Mitsias
Article full text
The article associated with this page has been accepted for online publication and is in the final stages of production. The pre-typeset version is available above.
© The authors, CC-BY-NC 2020.